Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Falck

Showing results (621-630 of 651) with videos related to

Pageof 66
Sort By:
Journal of Hypertension|March 24, 2018
Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertensionLuděk Červenka, Zuzana Husková, Libor Kopkan, et al.
The Journal of Biological Chemistry|May 1, 2001
Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brainW Qu, J A Bradbury, C C Tsao, et al.
Circulation Research|March 23, 2017
20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G<sub>q</sub>) to Affect Vascular Function and Trigger HypertensionVictor Garcia, Ankit Gilani, Brian Shkolnik, et al.
Clinical Science (London, England : 1979)|April 14, 2019
Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive ratsJan Neckář, Md Abdul Hye Khan, Garrett J Gross, et al.
Bioorganic & Medicinal Chemistry|June 6, 2003
20-hydroxyeicosatetraenoic acid (20-HETE): structural determinants for renal vasoconstrictionMing Yu, Magdalena Alonso-Galicia, Cheng-Wen Sun, et al.
Biomedicines|August 27, 2021
Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo EvaluationPetr Kala, Matúš Miklovič, Šárka Jíchová, et al.
Journal of Lipid Research|August 13, 2014
Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesityWeibin Zha, Matthew L Edin, Kimberly C Vendrov, et al.
The Journal of Biological Chemistry|March 16, 2011
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)Ranjana Mitra, Zhijun Guo, Monica Milani, et al.
Kidney International|October 22, 2010
Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injuryUwe Hoff, Ivo Lukitsch, Lyubov Chaykovska, et al.
Journal of the American Society of Nephrology : JASN|July 30, 2014
Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathyMahesha H Gangadhariah, James M Luther, Victor Garcia, et al.
Pageof 66

Showing results (621-630 of 651) with videos related to

Sort By:
Pageof 66
Journal of Hypertension|March 24, 2018
Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertensionLuděk Červenka, Zuzana Husková, Libor Kopkan, et al.
The Journal of Biological Chemistry|May 1, 2001
Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brainW Qu, J A Bradbury, C C Tsao, et al.
Circulation Research|March 23, 2017
20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G<sub>q</sub>) to Affect Vascular Function and Trigger HypertensionVictor Garcia, Ankit Gilani, Brian Shkolnik, et al.
Clinical Science (London, England : 1979)|April 14, 2019
Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive ratsJan Neckář, Md Abdul Hye Khan, Garrett J Gross, et al.
Bioorganic & Medicinal Chemistry|June 6, 2003
20-hydroxyeicosatetraenoic acid (20-HETE): structural determinants for renal vasoconstrictionMing Yu, Magdalena Alonso-Galicia, Cheng-Wen Sun, et al.
Biomedicines|August 27, 2021
Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo EvaluationPetr Kala, Matúš Miklovič, Šárka Jíchová, et al.
Journal of Lipid Research|August 13, 2014
Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesityWeibin Zha, Matthew L Edin, Kimberly C Vendrov, et al.
The Journal of Biological Chemistry|March 16, 2011
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)Ranjana Mitra, Zhijun Guo, Monica Milani, et al.
Kidney International|October 22, 2010
Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injuryUwe Hoff, Ivo Lukitsch, Lyubov Chaykovska, et al.
Journal of the American Society of Nephrology : JASN|July 30, 2014
Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathyMahesha H Gangadhariah, James M Luther, Victor Garcia, et al.
Pageof 66